ReviewBiomedicines2024

Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer.

Hasan Alsharoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.